Article
Generation of pancreatic progenitors from human pluripotent stem cells by small molecules
26 Aug 2021
Abstract excerpt
Human pluripotent stem cell (hPSC)-derived pancreatic progenitors (PPs) provide promising cell therapies for type 1 diabetes. Current PP differentiation requires a high amount of Activin A during the definitive endoderm (DE) stage, making it economically difficult for commercial ventures. Here we identify a dose-dependent role for Wnt signaling in controlling DE differentiation without Activin A. While high-level...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
